A research collaboration between Pentavere Research Group and Takeda Canada has led to the creation of one of the largest…
Articles by Mary Chapman
Hereditary Angioedema (HAE) Awareness Day is observed every May 16 to call attention to a disorder that affects an…
Adarx Pharmaceuticals will use $200 million in oversubscribed Series C financing to further develop its clinical programs — including…
BioCryst Pharmaceuticals has tapped Swixx BioPharma to commercialize the hereditary angioedema (HAE) treatment Orladeyo (berotralstat) in central…
To continue to improve patient access to top-shelf angioedema care, the global network of Angioedema Centers of Reference…
A new hereditary angioedema (HAE) registry, touted as the first of its kind, is using real-world data to provide…
HAE Awareness Day is observed around the world each May 16 to bring attention to hereditary angioedema (HAE) and…
With a goal of finding new digital technologies and artificial intelligence (AI) solutions for patients with rare genetic disorders like…
Cycle Pharmaceuticals has launched Sajazir, an injectable form of icatibant, as a new treatment option for acute attacks…
At its first virtual investor event, biotech company Centogene set a bold mission: to cure 100 rare diseases within…